Undifferentiated Embryonal Sarcoma of the Liver
Summary
Undifferentiated embryonal sarcoma of the liver is a rare, highly malignant mesenchymal neoplasm that predominantly affects children between six and ten years of age, with occasional occurrences in adolescents and adults. Clinically, it often presents with non-specific abdominal pain, hepatomegaly and systemic symptoms such as fever or weight loss. Imaging typically reveals a large, heterogeneous lesion with cystic and solid components, which can be mistaken for benign cysts or abscesses. Histopathological examination demonstrates pleomorphic spindle or stellate cells embedded in a myxoid stroma, frequently accompanied by eosinophilic globules and high mitotic activity. Definitive diagnosis relies on surgical biopsy with immunohistochemical staining, commonly showing positivity for vimentin and variable expression of desmin, α-smooth muscle actin and cytokeratins. Standard management involves complete surgical resection, whenever feasible, combined with multi-agent chemotherapy regimens. In unresectable or recurrent cases, orthotopic liver transplantation has emerged as a potential curative option in carefully selected patients. Despite aggressive treatment, long-term prognosis remains guarded, particularly in adults, although recent advances in combined modality therapy have improved survival in the paediatric population.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Undifferentiated Embryonal Sarcoma of the Liver publication trend
The graph below shows the total number of articles in undifferentiated embryonal sarcoma of the liver across all publications each year (not limited to Nature Index journals).
Technical terms
Mesenchymal tumour: A neoplasm derived from connective tissue cells such as fibroblasts, myofibroblasts or smooth muscle cells.
Myxoid stroma: A gelatinous extracellular matrix rich in glycosaminoglycans that provides a distinctive, mucoid appearance under microscopy.
Complete surgical resection: Removal of the entire tumour with a margin of healthy tissue to minimise residual microscopic disease.
Adjuvant chemotherapy: Systemic drug treatment administered after primary surgery to eradicate remaining malignant cells and reduce recurrence risk.
Orthotopic liver transplantation: Surgical procedure replacing the diseased liver with a donor liver in its normal anatomical location.
References
- Treatment of Undifferentiated Embryonal Sarcoma of the Liver in Children. Cancers (2024).
- Undifferentiated Embryonal Sarcoma of the Liver in Children Versus Adults: A National Cancer Database Analysis †. Cancers (2021).
- Unresectable Undifferentiated Embryonal Sarcoma of the Liver in an Adult Male Treated with Chemotherapy and Orthotopic Liver Transplantation. Cureus (2017).
- Rare Case of Adult Undifferentiated (Embryonal) Sarcoma of the Liver Treated with Liver Transplantation: Excellent Long‐Term Survival. Case Reports in Hepatology (2012).
- Clinicopathological study of hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a single center study from Iran. Diagnostic Pathology (2021).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.